The administration of S-Ketamine, a rapid and long-lasting antidepressant drug, reverses the reductions in expression and activity of hippocampal Rac1 and rescues CUMS-evoked LTP damage and depression-like behavior. Here, RAC1 is linked to major depressive disorder.